Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Massachusetts Healthcare Journal.

X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BOSTON, Aug. 15, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that, effective on August 12, 2025, the company issued inducement...

Massachusetts Residents May Qualify for No-Cost Energy Assessment and Upgrades Through Mass Save®
United Better Homes helps connect homeowners with energy-saving improvements across the state. ATTLEBORO, MA, UNITED STATES, August 14, 2025 /EINPresswire.com/ -- Homeowners across Massachusetts may be eligible for no-cost energy upgrades...

Rony Jabour Leads Workplace Emergency Preparedness Keynote in Boston During Safe + Sound Week
Harvard-trained safety leader Rony Jabour delivers keynote in Boston during OSHA’s Safe + Sound Week on workplace emergency preparedness. BOSTON, MA, UNITED STATES, August 14, 2025 /EINPresswire.com/ -- Rony Jabour, a renowned occupational...

Medical Device Technologies Market Anticipated to Reach USD 600.0 Billion by 2035, with a CAGR of 1.96%
Medical Device Technology Market Research Report By Product Type (Diagnostic Devices, Therapeutic Devices, Monitoring Devices, Surgical Devices, Access ) NEW YORK,, NY, UNITED STATES, August 13, 2025 /EINPresswire.com/ -- Medical Device...

RxSight, Inc. to Present at the Wells Fargo Healthcare Conference
ALISO VIEJO, Calif., Aug. 14, 2025 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the...

Eledon Pharmaceuticals Reports Second Quarter 2025 Operating and Financial Results
Updated data from ongoing open-label Phase 1b trial demonstrated a mean 12-month eGFR of approximately 68 mL/min/1.73 m2 post-transplant for patients on tegoprubart Company on track to report topline results from Phase 2 BESTOW trial in kidney...

Vitiligo Clinical Trial Pipeline Accelerates as 18+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight
New York, USA, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Vitiligo Clinical Trial Pipeline Accelerates as 18+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight The vitiligo treatment landscape is evolving with a shift towards...

Six Boston Residents to be Honored at Literacy Scholarship Ceremony
On Wednesday, August 27, 2025, the City of Boston Worker Empowerment Cabinet will host the 2025 First Literacy Scholarship Ceremony at Boston City Hall. The ceremony will celebrate 29 adult learners who were awarded First Literacy Scholarships for...

Stryker to participate in the 2025 Wells Fargo Securities Healthcare Conference
Portage, Michigan, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the 2025 Wells Fargo Securities Healthcare Conference on Thursday, September 4, at the Encore Boston Harbor. Andy Pierce, Group President, MedSurg and...

Manatt Welcomes Addiction Medicine and Substance Use Disorder Leader as National Advisor in Washington, D.C.
WASHINGTON, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Manatt, Phelps & Phillips, LLP, a multidisciplinary, integrated professional services firm, today announced the arrival of National Advisor Dr. Yngvild Olsen, MD, MPH, to the Firm’s Health Care group....

West Nile Virus Risk Level in Boston Raised to High
Boston Public Health Commission encourages residents to take precautions The Boston Public Health Commission (BPHC) is alerting residents that the Massachusetts Public Health Department raised the risk level for West Nile Virus in Boston to high....

X4 Pharmaceuticals Announces Closing of Upsized $85 Million Private Placement
BOSTON, Aug. 13, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today closed an upsized private placement of 11,040,776 shares of common stock...

Smart Medical Devices Market to Grow at 17.1% CAGR Through 2030
Boston, Aug. 13, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “Smart Medical Devices: Global Markets” is projected to grow from $87.7 billion in 2025 to $193.3 billion by the end of 2030, at a compound annual growth...

Hatteras Venture Partners Raises Over $200 Million in Capital Across Two Healthcare-Focused Funds
– Invests in 100th Portfolio Company, Celebrates 25th Year of Franchise Operation – – Announces Promotion of Lauren Flickinger and Ben Scruggs, Ph.D., as Partners – DURHAM, N.C., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Hatteras Venture Partners...

Autonomous Robots Market to Reach USD 34.64 Billion by 2035, Powered by Healthcare and Logistics Demand
Autonomous Robots Market Research Report By Product, Mode of Operations, End-User, Regional IN, UNITED STATES, August 13, 2025 /EINPresswire.com/ -- The Autonomous Robots Market was valued at USD 6.5 Billion in 2023 and is projected to grow...

Medical Devices Market Poised for Major Shift – Key Players and Trends Uncovered
Explore global medical devices market trends, growth drivers, innovations, and future opportunities in healthcare technology. NEW YORK, NY, UNITED STATES, August 11, 2025 /EINPresswire.com/ -- Comprehensive Market Research Report: In-Depth...

Nitinol Medical Device Market Anticipated to Reach USD 6.5 Billion, at a Notable 5.4% CAGR by 2035
Nitinol Medical Device Market Gains Momentum as Shape-Memory Innovation Transforms Medical Technology US, NY, UNITED STATES, August 12, 2025 /EINPresswire.com/ -- The Nitinol Medical Device Market is entering a period of sustained growth, fueled...

Quesito El Establo Recalls Spanish Cheese (Quesito Colombiano) Because of Possible Health Risk
COMPANY ANNOUNCEMENT When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company. Read Announcement View Product Photos...

Quesito El Establo Recalls Spanish Cheese (Quesito Colombiano) Because of Possible Health Risk
COMPANY ANNOUNCEMENT When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company. Read Announcement View Product Photos...

Wegmans Food Markets, Inc. Recalls Various Wegmans Camembert Soft Ripened Cheese Products Because of Possible Health Risk
COMPANY ANNOUNCEMENT When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company. Read Announcement View Product Photos...